Skip to main content
. 2021 Apr 22;11:646211. doi: 10.3389/fonc.2021.646211

Table 3.

Independent sample t test of OARs’ dose-volume parameters between PBM sparing IMRT group and non-PBM sparing IMRT group (x¯±s).

Dose-volume parameters Bladder P Small bowel P Left femoral head P Right femoral head P
PBM sparing IMRT (%) non-PBM sparing IMRT (%) PBM sparing IMRT (cc) non-PBM sparing IMRT (cc) PBM sparing IMRT (%) non-PBM sparing IMRT (%) PBM sparing IMRT (%) non-PBM sparing IMRT (%)
V 5 100.0 ± 0.0 100.0 ± 0.0 0.285 1053 ± 535 1056 ± 370 0.968 79.8 ± 15.6 95.0 ± 7.5 <0.001 78.6 ± 17.8 94.7 ± 8.0 <0.001
V 10 100.0 ± 0.2 100.0 ± 0.0 0.354 984 ± 499 995 ± 353 0.896 53.7 ± 20.6 84.9 ± 15.0 <0.001 53.8 ± 21.7 84,.0 ± 16.4 <0.001
V 15 99.9 ± 1.1 99.9 ± 0.5 0.749 907 ± 456 934 ± 336 0.722 37.2 ± 18.5 74.1 ± 19.9 <0.001 36.2 ± 19.7 73.9 ± 20.6 <0.001
V 20 99.1 ± 3.1 99.3 ± 1.8 0.718 806 ± 390 840 ± 314 0.614 23.7 ± 13.7 57.4 ± 21.4 <0.001 23.2 ± 17.2 55.7 ± 20.8 <0.001
V 25 94.4 ± 7.9 96.3 ± 5.6 0.141 663 ± 281 683 ± 265 0.691 12.9 ± 9.3 35.9 ± 17.3 <0.001 12.6 ± 12.1 33.6 ± 17.2 <0.001
V 30 82.2 ± 13.7 86.5 ± 9.8 0.062 503 ± 209 532 ± 215 0.583 6.0 ± 5.8 20.4 ± 12.5 <0.001 5.8 ± 6.1 18.4 ± 12.6 <0.001
V 35 64.2 ± 16.5 67.9 ± 12.3 0.182 372 ± 161 391 ± 176 0.552 2.6 ± 3.4 8.3 ± 5.3 <0.001 2.6 ± 3.5 7.6 ± 6.2 <0.001
V 40 47.9 ± 16.4 49.8 ± 13.4 0.505 268 ± 122 280 ± 142 0.625 1.0 ± 1.7 2.5 ± 2.7 0.001 1.0 ± 2.0 2.5 ± 2.7 0.001
V 45 33.5 ± 14.8 33.0 ± 12.9 0.838 193 ± 98 199 ± 118 0.784 0.3 ± 0.6 0.6 ± 1.1 0.068 0.4 ± 0.9 0.5 ± 0.9 0.358
V 50 16.8 ± 11.7 15.4 ± 10.9 0.523 110 ± 74 104 ± 94 0.688 0.0 ± 0.0 0.1 ± 0.3 0.284 0.0 ± 0.2 0.0 ± 0.1 0.946
Dmean 3932 ± 356 3977 ± 272 0.388 3009 ± 418 3069 ± 432 0.459 1340 ± 393 2146 ± 433 0.001 1318 ± 436 2114 ± 436 <0.001